Literature DB >> 15225516

Lung cancer incidence in the province of Avila, Spain in 2002 and decade-long trends.

J R Hernández Hernández1, J A Tapias del Pozo, P Moreno Canelo, A Rodríguez Puebla, S Paniagua Tejo, J C Sánchez Marcos.   

Abstract

OBJECTIVES: To determine lung cancer incidence in the province of Avila, Spain, in the year 2002 and compare it with incidences reported in 2 previous studies (for 1992-1993 and 1997). PATIENTS AND METHODS: Patients diagnosed in 2002 were evaluated prospectively by the method used in the previous studies. The reference population was obtained from the municipal records for 2001.
RESULTS: In 2002, 87 patients (74 men and 13 women) were diagnosed with lung cancer. The crude incidence rate was 53.09 cases per 100 000 population (men: 89.92/100 000; women: 15.93/100 000). Of these, 87.3% had been smokers. Squamous cell carcinomas were the most frequent type overall (38.1%) and in men (42.4%). Adenocarcinomas were the most frequent type in women (60%). The most frequent treatment was chemotherapy (35.6%). Between the 1992-1993 study and our 2002 study, significant increases were found in crude incidence rates of lung cancer and the use of chemotherapy, as well as significant decreases both in squamous cell carcinomas and the use of radiotherapy alone.
CONCLUSIONS: Between 1992 and 2002 the lung cancer incidence in men and women in the province of Avila increased significantly.

Entities:  

Mesh:

Year:  2004        PMID: 15225516

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  2 in total

1.  [Epidemiological Evolution of Lung Cancer in the South of Spain from 1990 to 2010].

Authors:  Alberto Caballero Vázquez; Ana Dolores Romero Ortiz; Jose Manuel González de Vega San Román; Raimundo García Del Moral; Bernardino Alcázar Navarrete
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-01-20

2.  Pattern of use of radiotherapy for lung cancer: a descriptive study.

Authors:  Isabel Tovar; Jose Expósito; Javier Jaén; Enrique Alonso; Miguel Martínez; Rosa Guerrero; Juan P Arrebola; Rosario Del Moral
Journal:  BMC Cancer       Date:  2014-09-23       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.